SCHEMBL21140999

SCHEMBL21140999

c1ccc(-c2ccc(N(c3ccc4c(c3)-c3ccccc3-c3ccccc3-c3ccccc3-4)c3ccc4oc5ccccc5c4c3)c(-c3ccccc3)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.38
▸ RAB9A P51151 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ LMNA P02545 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ APAF1 O14727 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ XBP1 P17861 1/20 0.38
▸ PTBP1 P26599 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ GALK1 P51570 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ SMAD3 P84022 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ PLA2G2A P14555 5/20 0.37
▸ PLA2G4A P47712 5/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22435713 0.94 PLA2G2A (0.41) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL21141459 0.93 MEN1 (0.38) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL22435671 0.93 PLA2G2A (0.40) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL22435682 0.92 PLA2G2A (0.38) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL21975858 0.91 PLA2G2A (0.39) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL22435678 0.91 PLA2G2A (0.37) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL22435670 0.90 PLA2G2A (0.40) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL21976168 0.90 PLA2G2A (0.39) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL22435672 0.90 PLA2G2A (0.39) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL22435706 0.90 NPC1 (0.39) NPC1RAB9ASMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11512038-B2 Tetraphenylene triarylamine compounds Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-11-29 — — US disclosed
US-20190185412-A1 TETRAPHENYLENE TRIARYLAMINE COMPOUNDS Beijing Summer Sprout Technology Co., Ltd. (CN) 2019-06-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11512038-B2 Tetraphenylene triarylamine compounds OCIAD2, OCIAD1, SLC7A5 NPC1 125/4885RAB9A 1835/4885SMN1; SMN2 4090/4885
US-20190185412-A1 TETRAPHENYLENE TRIARYLAMINE COMPOUNDS OCIAD2, OCIAD1, SLC7A5 NPC1 125/4885RAB9A 1835/4885SMN1; SMN2 4090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback